Congratulations to our brilliant Cure Cancer 2024 Researcher Of The Year Award winners 🔬🧡
We celebrated the groundbreaking work Dr Asmerom Sengal & Dr Marjan Naeini who were honoured as finalists, & Dr Yuchen Feng was named Researcher of the Year 2024!
https://t.co/zl7U5UskoE
Happy to share our recent paper which was published in Nature Precision Oncology last week. The study opens a new avenue of personalised treatment options for endometrial cancer patients. https://t.co/9zHasuTEEJ
#Endometrialcancer is an exception with a trend of remarkable increase in both incidence and mortality. It's less funded and researched. Tomorrow at 12:30PM local time a "Lunch and Learn" session will be held hosted by #CureCancer to increase awareness https://t.co/ZIqXnRgq9t
Excited to join the @PLOSONE Editorial Board, an #OpenScience journal publishing trusted research in over 200 subject areas across science, engineering, medicine and the related social sciences and humanities.
Delighted to be one of the Cure Cancer ECR grant scheme 2023 awardee. Thank you #CureCancer for the generous support to fund cutting edge research. https://t.co/KiZbRiPD6W
🎉💜 World Cancer Day Announcement
We're funding 14 brilliant cancer researchers in 2023!
Thanks to your support, we're funding innovative research for those affected by cancer.
Check out our researchers: https://t.co/abT0vu4n7m
#WorldCancerDay#CancerResearch
If #Eritrea can produce a world beating athletes in sports that require heavy investment and long term strategy under tremendous amount of existential national threat; imagine the possibilities if it were free to reach its potential @GrmayeBiniam#EritreaPrevails
@martinplaut We have a very descriptive proverb in our local language that matches your propaganda about #Eritrea and Ethiopia " nadgi zeykebedos nmetsan kebedo" literally means a load that doesn't overload a donkey overloads for a robe
Our paper has recently been published in the Journal of Pathology: Clinical Research. In this article, we have demonstrated the role of the two #FGFR2 splice isoforms (FGFR2b and FGFR2c) in stratifying #endometrial#cancer.
https://t.co/rB4ITBvjbA
@anzgog@BnePam I am thrilled to be part of #ANZGOG ASM, pure science symposium speaker. "pathaways to Precision Care" Targeting with #FGFR inhibitors in #endometrialcancer preclinical models with #FGFR2 splice isoform switching. A novel finding
Next up is Dr Asmeron Sengal from A/Prof @BnePam
's group presenting on the role of FGFR2 dysregulation (isoform switching) in endometrial cancer & the efficacy of FGFR inhibition in endometrial cancer patient derived models with FGFR2c splice isoform expression #ANZGOG2022ASM
@djmarsh24@anzgog@DrCFord@nikolabowden Generally, the sessions were great but it was not fair not giving equal allocated time for Q&A for all prsenters when mediating the session.